Ipsen SA, of Paris, reported additional data from a phase III study testing Dysport in spastic equinus foot, a condition associated with cerebral palsy (CP) in children, ages 2 to 17. Data, presented at the American Academy for Cerebral Palsy and Developmental Medicine meeting in Austin, Texas, showed that, at week four, muscle tone was improved in patients treated with Dysport vs. placebo, as measured by a change in the Modified Ashworth Scale (MAS).